Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$60.67 - $89.12 $0 - $0
0 New
0 $0
Q3 2022

Nov 03, 2022

BUY
$61.1 - $83.78 $61 - $83
1 New
1 $0

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.1B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Strengthening Families & Communities, LLC Portfolio

Follow Strengthening Families & Communities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strengthening Families & Communities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strengthening Families & Communities, LLC with notifications on news.